PharmTech LCGC Sciex Webinar 11.10
|Articles|May 1, 2009

LCGC Europe eNews

  • LCGC Europe eNews-05-01-2009
  • Volume 0
  • Issue 0

Thermo Fisher Scientific acquires Biolab

Thermo Fisher Scientific has announced that it will acquire Biolab, a leading provider of analytical instruments, life science consumables and laboratory equipment for scientific, environmental and healthcare markets in Australia and New Zealand.

Thermo Fisher Scientific has announced that it has entered into an agreement to acquire Biolab, a leading provider of analytical instruments, life science consumables and laboratory equipment for scientific, environmental and healthcare markets in Australia and New Zealand, for AUD $175 million.

"As the premier commercial channel in Australia, New Zealand and the South Pacific, Biolab offers a broad portfolio of products and services to support Thermo Fisher's continued growth in the region," said Marijn E. Dekkers, president and chief executive officer of Thermo Fisher Scientific. "This acquisition significantly strengthens our presence in these markets, and will enable us to better serve customers in both public and private sectors through an expanded range of offerings."

Biolab has annual revenues of approximately AUD $170 and will be integrated into Thermo Fisher's Laboratory Products and Services Segment.

For more information about Thermo Fisher Scientific visit www.thermofisher.com

Articles in this issue

over 17 years ago

Researchers enter the Crucible

Related to this article

Best of the Week: From Cancer Diagnostics to Smarter LC Method Development
This week, Chromatography Online’s coverage spanned lipidomics-based early cancer detection, career paths in separation science, machine learning and uncertainty-driven approaches to LC method development, new EU wastewater rules for pharmaceutical micropollutants, automated Separation Quality Factor (SQF) evaluation in chromatography data systems, and solutions to GLP-1 peptide analysis challenges.